Market Place
Sourcing Support
All News #Library
Biotech
Edgewise Therapeutics To Present At Guggenheim Biotech Summit
05 Feb 2026 //
PR NEWSWIRE
Edgewise Reports Inducement Grants as permitted by Nasdaq LR
02 Feb 2026 //
PR NEWSWIRE
Edgewise Therapeutics Completes EDG-7500 Phase 2 Trial
24 Dec 2025 //
PR NEWSWIRE
Edgewise Therapeutics Reports Nasdaq Inducement Grants
02 Dec 2025 //
PR NEWSWIRE
Edgewise Therapeutics Appoints Christopher Martin To Board
20 Nov 2025 //
PR NEWSWIRE
Edgewise Therapeutics Reveals Q3 2025 Financials & Business
06 Nov 2025 //
PR NEWSWIRE
Edgewise to Show Sevasemten Data for Becker, Duchenne Dystrophy
02 Oct 2025 //
PR NEWSWIRE
Edgewise Therapeutics Reports Q2 2025 Financials and Business
08 Aug 2025 //
PR NEWSWIRE
Edgewise Shares Sevasemten Data in Becker & Duchenne Dystrophies
26 Jun 2025 //
PR NEWSWIRE
Edgewise Therapeutics Reports Q1 2025 Financial Results
08 May 2025 //
PR NEWSWIRE
Edgewise Stock Up 50% On Heart Disease Drug Data
19 Sep 2024 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.